A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

NCT06592989 · clinicaltrials.gov ↗

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neuroendocrine Neoplasm
Sorafenib
Gefitinib

Interventions

DRUG: sorafenib, gefitinib

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine